Brazil's first subscription service for medical cannabis
Innovation as a driver for accessing medical cannabis? In Brazil, a first subscription service focused on cannabis-based therapies has just been launched.
Managed by Gravital, a clinic specializing in medical cannabis treatments, the Gravital Club aims to facilitate access to this type of care, while offering a wider range of care. The principle of Gravital Club is also to promote well-being and encourage preventive and integrative medicine.
The Brazil authorized medical cannabis in 2019, whose products currently have to be imported.
According to Joaquim Castro, founder of Gravital Clinic, the subscription is an alternative for people looking to improve their quality of life and well-being.
«Our team of doctors has emphasized the importance of more closely monitoring patient progress. The intention of the Gravital Club »is to offer its members increasingly consistent results through cannabis therapy," he says.
Subscription plans
The Gravity ClubI propose two subscription options: Orbita III and Orbita IV. With these plans, patients can benefit from three or four medical consultations per year at the Gravital clinic, respectively, conducted in person or via teleconsultation. Both modalities can be scheduled with any doctor in the network and with different specialists, from any available specialty at the clinic.
For in-person consultations, Gravital has units in several cities in Brazil: Rio de Janeiro, São Paulo, Sorocaba, Curitiba, Itajaí, Porto Alegre, and Natal.
With both plans, subscribers receive a 20% discount on consultations beyond those already included, a 15% discount at the Gravital bookstore, and exclusive discounts on prescription medications. Also included is a subscription to Alternnativa magazine, a quarterly publication featuring the latest information on advances in medical cannabis.
About Gravital
Founded in Rio de Janeiro in 2019, the Gravital Clinic is the first clinic in Brazil focused on medical cannabis treatments. It currently has seven facilities in the country. Thanks to a multidisciplinary team, it treats patients suffering from clinical conditions such as insomnia, autoimmune diseases, chronic pain, fibromyalgia, migraines, autism, and neurodegenerative diseases like Parkinson's and Alzheimer's, among others.
-
Cannabis in Africa1 week ago
Nigeria moves a step closer to legalizing medical cannabis
-
Cannabis in France1 week ago
Le Champ d’en Face aims to bring hemp back into the public discourse
-
Cannabis in France1 week ago
French CBD industry to challenge CBD product control plan in court
-
Cannabis in the Caribbean1 week ago
Antigua and Barbuda: When Cannabis Becomes a Cultural Destination and a Tool for Sovereignty
-
Cannabinoids1 week ago
Japan bans CBN
-
Business1 week ago
Germany imported over 50 tonnes of medical cannabis in the first quarter of 2026
-
Business2 days ago
Europe authorizes the first cannabis-derived medicine for the treatment of chronic pain
-
Cannabis in the U.S.1 week ago
Trump's reclassification of cannabis is being challenged in court


You must be logged in to post a comment Login